Devan V Mehrotra - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Devan V Mehrotra

Showing results (71-80 of 76) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 76 results.

Plos One|September 3, 2015

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.

AIDS Research and Human Retroviruses|February 1, 2007

Evaluation of cellular immune responses in subjects chronically infected with HIV type 1Tong-Ming Fu, Sheri A Dubey, Devan V Mehrotra, et al.

The Journal of Infectious Diseases|April 6, 2005

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continentsPaul M Coplan, Swati B Gupta, Sheri A Dubey, et al.

Annals of Internal Medicine|October 22, 2020

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine TrialsDevan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.

Medrxiv : the Preprint Server for Health Sciences|December 18, 2020

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy TrialsDean Follmann, Jonathan Fintzi, Michael P Fay, et al.

Annals of Internal Medicine|April 12, 2021

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is VaccinatedDean Follmann, Jonathan Fintzi, Michael P Fay, et al.

Pageof 8

Search research articles

Showing results (71-80 of 76) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 76 results.

Plos One|September 3, 2015

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.

AIDS Research and Human Retroviruses|February 1, 2007

Evaluation of cellular immune responses in subjects chronically infected with HIV type 1Tong-Ming Fu, Sheri A Dubey, Devan V Mehrotra, et al.

The Journal of Infectious Diseases|April 6, 2005

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continentsPaul M Coplan, Swati B Gupta, Sheri A Dubey, et al.

Annals of Internal Medicine|October 22, 2020

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine TrialsDevan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.

Medrxiv : the Preprint Server for Health Sciences|December 18, 2020

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy TrialsDean Follmann, Jonathan Fintzi, Michael P Fay, et al.

Annals of Internal Medicine|April 12, 2021

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is VaccinatedDean Follmann, Jonathan Fintzi, Michael P Fay, et al.

Pageof 8